Rodriguez P, Breslaw N, Xiao H, Bena J, et al. De-intensification of basal-bolus therapy by replacing prandial insulin with once-weekly subcutaneous semaglutide in individuals with well-controlled type 2 diabetes: A single-centre, open-label randomised trial (TRANSITION-T2D). Diabetes Obes Metab 2024 Nov 12. doi: 10.1111/dom.16057.
PMID: 39532398